EP3851856A3 - Procédé, réseau et son utilisation - Google Patents
Procédé, réseau et son utilisation Download PDFInfo
- Publication number
- EP3851856A3 EP3851856A3 EP20214718.7A EP20214718A EP3851856A3 EP 3851856 A3 EP3851856 A3 EP 3851856A3 EP 20214718 A EP20214718 A EP 20214718A EP 3851856 A3 EP3851856 A3 EP 3851856A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- determining
- test sample
- pancreatic adenocarcinoma
- amount
- array
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title abstract 3
- 206010052747 Adenocarcinoma pancreas Diseases 0.000 abstract 3
- 201000002094 pancreatic adenocarcinoma Diseases 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0705876A GB0705876D0 (en) | 2007-03-27 | 2007-03-27 | Method, array and use thereof |
GB0712181A GB0712181D0 (en) | 2007-06-25 | 2007-06-25 | Method, array and use thereof |
PCT/GB2008/001090 WO2008117067A2 (fr) | 2007-03-27 | 2008-03-25 | Procédé, assemblage et utilisation de celui-ci |
EP08718919.7A EP2140269B1 (fr) | 2007-03-27 | 2008-03-25 | Procédé, assemblage et utilisation de celui-ci |
EP12163644A EP2490025A3 (fr) | 2007-03-27 | 2008-03-25 | Procédé, réseau et son utilisation |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12163644A Division EP2490025A3 (fr) | 2007-03-27 | 2008-03-25 | Procédé, réseau et son utilisation |
EP08718919.7A Division EP2140269B1 (fr) | 2007-03-27 | 2008-03-25 | Procédé, assemblage et utilisation de celui-ci |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3851856A2 EP3851856A2 (fr) | 2021-07-21 |
EP3851856A3 true EP3851856A3 (fr) | 2021-11-03 |
Family
ID=39493874
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12163644A Withdrawn EP2490025A3 (fr) | 2007-03-27 | 2008-03-25 | Procédé, réseau et son utilisation |
EP08718919.7A Active EP2140269B1 (fr) | 2007-03-27 | 2008-03-25 | Procédé, assemblage et utilisation de celui-ci |
EP20214718.7A Pending EP3851856A3 (fr) | 2007-03-27 | 2008-03-25 | Procédé, réseau et son utilisation |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12163644A Withdrawn EP2490025A3 (fr) | 2007-03-27 | 2008-03-25 | Procédé, réseau et son utilisation |
EP08718919.7A Active EP2140269B1 (fr) | 2007-03-27 | 2008-03-25 | Procédé, assemblage et utilisation de celui-ci |
Country Status (10)
Country | Link |
---|---|
US (3) | US20100105571A1 (fr) |
EP (3) | EP2490025A3 (fr) |
JP (3) | JP6115801B2 (fr) |
CN (2) | CN107102142A (fr) |
AU (3) | AU2008231575A1 (fr) |
CA (1) | CA2681899C (fr) |
DK (1) | DK2140269T3 (fr) |
ES (1) | ES2442919T3 (fr) |
PL (1) | PL2140269T3 (fr) |
WO (1) | WO2008117067A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107102142A (zh) | 2007-03-27 | 2017-08-29 | 伊缪诺维亚公司 | 检测腺癌的蛋白标志/标记 |
GB0723179D0 (en) * | 2007-11-27 | 2008-01-02 | Immunovia Ab | Diagnostic methods and arrays for use in the same |
US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
EP2415877A3 (fr) * | 2010-02-17 | 2012-02-15 | Deutsches Krebsforschungszentrum | Moyens et procédés pour diagnostiquer un cancer pancréatique |
GB201009798D0 (en) | 2010-06-11 | 2010-07-21 | Immunovia Ab | Method,array and use thereof |
SG186953A1 (en) | 2010-07-09 | 2013-02-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
MX341517B (es) * | 2010-08-13 | 2016-08-24 | Somalogic Inc | Biomarcadores de cancer pancreatico y usos de los mismos. |
GB201103726D0 (en) * | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
KR20150129932A (ko) | 2014-05-12 | 2015-11-23 | 연세대학교 산학협력단 | 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트 |
GB201516801D0 (en) | 2015-09-22 | 2015-11-04 | Immunovia Ab | Method, array and use thereof |
RU2627448C1 (ru) * | 2016-04-05 | 2017-08-08 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Способ иммуногистохимического выявления антигенов в препаратах органов продуктивных и непродуктивных животных длительного хранения в фиксаторах |
GB201608192D0 (en) * | 2016-05-10 | 2016-06-22 | Immunovia Ab | Method, array and use thereof |
GB201701572D0 (en) | 2017-01-31 | 2017-03-15 | Immunovia Ab | Methods, arrays and uses thereof |
GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004055519A2 (fr) * | 2002-12-17 | 2004-07-01 | Sinogenomax Co. Ltd. | Marqueurs specifiques pour le cancer du pancreas |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE12586T1 (de) | 1980-05-02 | 1985-04-15 | Edward P Davis | Beinentlastungsgeraet. |
US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
CA1202235A (fr) * | 1983-08-30 | 1986-03-25 | Paul S. Satoh | Dosage immunologique de fragments de complement |
US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
GB9704444D0 (en) * | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
JP2003506016A (ja) | 1999-02-19 | 2003-02-18 | ザ ユニヴァーシティー オブ アイオワ リサーチ ファンデーション | 動脈壁破裂障害のための診断剤および治療剤 |
JP4619651B2 (ja) | 2001-06-01 | 2011-01-26 | コーネル・リサーチ・ファンデーション・インコーポレイテッド | 前立腺特異的膜抗原に対する修飾抗体およびその使用 |
CA2500472A1 (fr) | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Genes et polypeptides associes aux cancers du pancreas chez l'homme |
US20050260639A1 (en) * | 2002-09-30 | 2005-11-24 | Oncotherapy Science, Inc. | Method for diagnosing pancreatic cancer |
EP1416279B1 (fr) | 2002-10-31 | 2008-12-31 | F. Hoffmann-La Roche Ag | Methodes et compositions pour le diagnostic du cancer du pancreas |
JP3857241B2 (ja) * | 2003-02-17 | 2006-12-13 | スパンション インク | 昇圧電源の振幅を小さくしたチャージポンプ回路 |
JP4194080B2 (ja) * | 2003-02-19 | 2008-12-10 | 茂 森村 | 膵癌検出用マーカー |
AU2004229501B2 (en) | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
US20040248205A1 (en) * | 2003-04-16 | 2004-12-09 | Stern Lawrence J. | Major histocompatibility complex (MHC)-peptide arrays |
WO2004099432A2 (fr) | 2003-05-02 | 2004-11-18 | The Johns Hopkins University | Identification de biomarqueurs permettant de detecter la presence d'un cancer du pancreas |
EP1638510B1 (fr) | 2003-07-01 | 2015-09-02 | Immunomedics, Inc. | Porteuses polyvalentes d'anticorps bispecifiques |
JP4663634B2 (ja) * | 2003-07-10 | 2011-04-06 | 財団法人実験動物中央研究所 | 腫瘍転移の分析のための動物モデル |
US20050277137A1 (en) | 2003-08-15 | 2005-12-15 | University Of Pittsburgh | Diagnostic multimarker serological profiling |
AU2004309111B2 (en) * | 2003-12-24 | 2011-02-24 | Merck Serono Sa | CC-chemokine-binding tick proteins |
US20060106119A1 (en) * | 2004-01-12 | 2006-05-18 | Chang-Jie Guo | Novel integration for CO and H2 recovery in gas to liquid processes |
BR122018073034B1 (pt) | 2004-05-28 | 2021-10-13 | Agensys, Inc | Anticorpos e moléculas relacionadas que se ligam à proteínas de psca |
US8383357B2 (en) | 2005-03-16 | 2013-02-26 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
AU2006235258A1 (en) | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics Inc. | Cancer-related genes |
CA2604885A1 (fr) * | 2005-04-07 | 2006-10-19 | Guoying Yu | Cacna1e dans le diagnostic, la detection et le traitement du cancer |
US8632983B2 (en) | 2005-04-15 | 2014-01-21 | Van Andel Research Institute | Biomarkers for pancreatic cancer and diagnostic methods |
CN1851455B (zh) | 2005-04-22 | 2010-11-10 | 复旦大学附属中山医院 | 一种肿瘤标志物-血清蛋白指纹图谱的检测方法 |
US7776550B2 (en) * | 2005-05-05 | 2010-08-17 | Philadelphia Health & Education Corporation | Diagnosis of liver pathology through assessment of protein glycosylation |
EP1736780A1 (fr) * | 2005-06-24 | 2006-12-27 | Eppendorf Array Technologies S.A. | Procédé et dispositives pour la détection et/ou la quantification de changements hierarchicaux moleculairs de une réponse cellulaire à un stimulus externe |
JP2007051880A (ja) * | 2005-08-15 | 2007-03-01 | Tokyo Univ Of Science | 膵臓癌の検出方法、膵臓癌の診断キット |
EP2412822A1 (fr) | 2006-01-11 | 2012-02-01 | Genomic Health, Inc. | Marqueurs de l'expression génique pour le pronostic du cancer colorectal |
WO2007107774A2 (fr) | 2006-03-22 | 2007-09-27 | Cartela R & D Ab | Nouvelles méthodes de diagnostic et de traitement |
WO2007122820A1 (fr) | 2006-04-18 | 2007-11-01 | Perseus Proteomics Inc. | Agent diagnostique et agent therapeutique pour le cancer du pancreas |
US20080038301A1 (en) * | 2006-08-08 | 2008-02-14 | The Procter & Gamble Company | Personal care product comprising collapsible water-containing capsules |
KR100819122B1 (ko) | 2006-09-30 | 2008-04-04 | 남명진 | 췌장암 진단용 키트 |
WO2008079269A2 (fr) * | 2006-12-19 | 2008-07-03 | Genego, Inc. | Nouveaux procédés pour une analyse fonctionnelle de données expérimentales à haut débit et groupes de gènes identifiés à partir de ceux-ci |
CN101246176B (zh) | 2007-02-13 | 2013-06-05 | 许洋 | 鳞状细胞癌抗原阴性***血清蛋白质检测的质谱试剂及其制备方法 |
CN107102142A (zh) | 2007-03-27 | 2017-08-29 | 伊缪诺维亚公司 | 检测腺癌的蛋白标志/标记 |
GB0709092D0 (en) | 2007-05-11 | 2007-06-20 | Borrebaeck Carl | Diagnosis and method of disease |
NZ555363A (en) | 2007-05-24 | 2009-11-27 | Pacific Edge Biotechnology Ltd | Prognosis prediction for melanoma cancer |
EP2637020A3 (fr) | 2007-06-29 | 2014-01-08 | Correlogic Systems Inc. | Marquers prédictifs du cancer de l'ovaire |
EP2217625B1 (fr) | 2007-11-08 | 2021-08-04 | Precision Biologics, Inc. | Anticorps monoclonaux recombinants et antigènes correspondants pour des cancers du côlon et du pancréas |
GB0723179D0 (en) | 2007-11-27 | 2008-01-02 | Immunovia Ab | Diagnostic methods and arrays for use in the same |
WO2009111067A2 (fr) | 2008-03-07 | 2009-09-11 | Osi Pharmaceuticals, Inc. | Procédés pour l’identification d’agents inhibant des cellules tumorales de nature mésenchymateuse ou leur formation |
GB0815846D0 (en) | 2008-09-01 | 2008-10-08 | Immunovia Ab | diagnosis, prognosis and imaging of disease |
CN101676300B (zh) | 2008-09-16 | 2012-05-02 | 中国科学院生物物理研究所 | 一种抑制人结肠肿瘤生长的新型抗体及其在制备用于早期诊断结直肠癌、子宫内膜癌以及胰腺癌的诊断剂中的应用 |
CN101451975B (zh) | 2008-12-29 | 2012-01-25 | 浙江大学 | 一种检测胃癌预后与分期血清蛋白质的方法 |
WO2010102195A2 (fr) | 2009-03-06 | 2010-09-10 | The Johns Hopkins University | Gène de l'annexine a11 et gènes associés en tant que biomarqueurs pour le cancer |
EP2857522A3 (fr) | 2009-03-12 | 2015-10-14 | Cancer Prevention And Cure, Ltd. | Procédés d'identification, d'évaluation, de prévention et de thérapie de maladies des poumons et leurs kits comprenant une identification, une évaluation, une prévention et une thérapie de maladies basées sur le sexe |
CN101880707A (zh) | 2009-05-05 | 2010-11-10 | 中国人民解放军第二军医大学 | microRNA-21在鉴别胰腺癌中的应用 |
CN101613748A (zh) | 2009-06-09 | 2009-12-30 | 中国人民解放军第二军医大学 | 一种检测胰腺癌血清标志物的方法 |
RU2421149C2 (ru) | 2009-07-16 | 2011-06-20 | Ольга Васильевна Кокуева | Способ дифференциальной диагностики рака поджелудочной железы и хронического панкреатита |
SG168431A1 (en) | 2009-07-23 | 2011-02-28 | Univ Singapore | Cancer biomarker and the use thereof |
WO2011039289A1 (fr) | 2009-09-29 | 2011-04-07 | Protagen Ag | Séquences de marqueurs pour affections cancéreuses du pancréas, carcinome pancréatique et leur utilisation |
CN102279264A (zh) | 2010-06-09 | 2011-12-14 | 李彬 | 48种恶性肿瘤标志物抗体芯片的制备方法 |
WO2012021407A2 (fr) | 2010-08-13 | 2012-02-16 | Morehouse School Of Medicine | Biomarqueurs pour accident vasculaire cérébral |
WO2012031374A1 (fr) | 2010-09-09 | 2012-03-15 | 北京同为时代生物技术有限公司 | Marqueurs sanguins utilisables en vue du diagnostic de cancers d'origine épithéliale et anticorps monoclonaux dirigés contre lesdits marqueurs |
GB201103726D0 (en) | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
CN102201038B (zh) | 2011-04-27 | 2013-06-05 | 浙江大学 | 脑瘤p53蛋白表达检测方法 |
CN102286464B (zh) | 2011-06-30 | 2013-07-17 | 眭维国 | ***长链非编码核糖核酸差异性表达图谱模型及其构建方法 |
WO2013052480A1 (fr) | 2011-10-03 | 2013-04-11 | The Board Of Regents Of The University Of Texas System | Score de risque pronostique de cancer du côlon basé sur des marqueurs |
WO2013106844A2 (fr) | 2012-01-13 | 2013-07-18 | Oncocyte Corporation | Procédés et compositions pour le traitement et le diagnostic du cancer du pancréas |
WO2014089241A2 (fr) | 2012-12-04 | 2014-06-12 | Caris Mpi, Inc. | Profilage moléculaire pour cancer |
TWI658049B (zh) | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Kntc2胜肽及含此胜肽之疫苗 |
WO2014160499A2 (fr) | 2013-03-13 | 2014-10-02 | Creatics Llc | Procédés et compositions pour détecter un cancer du pancréas |
EP2972374A2 (fr) | 2013-03-15 | 2016-01-20 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Biomarqueurs basés sur le rapport et leur procédés d'utilisation |
JP6683986B2 (ja) | 2013-07-10 | 2020-04-22 | 国立大学法人 東京大学 | がん幹細胞分子マーカー |
GB201319878D0 (en) | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
WO2015112429A1 (fr) | 2014-01-23 | 2015-07-30 | Newomics Inc | Procédés et systèmes pour diagnostiquer des maladies |
WO2015157557A1 (fr) | 2014-04-09 | 2015-10-15 | Myriad Rbm, Inc. | Procédés de diagnostic du cancer du pancréas et procédés associés |
US10451628B2 (en) | 2014-05-07 | 2019-10-22 | University Of Utah Research Foundation | Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma |
KR20150129932A (ko) | 2014-05-12 | 2015-11-23 | 연세대학교 산학협력단 | 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트 |
GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
CN105092845A (zh) | 2015-07-10 | 2015-11-25 | 深圳市贝沃德克生物技术研究院有限公司 | 胰腺癌蛋白生物标记物、用途及其检测芯片和检测装置 |
CN105092844A (zh) | 2015-07-10 | 2015-11-25 | 深圳市贝沃德克生物技术研究院有限公司 | 胰腺癌蛋白生物标记物的检测试剂盒及检测*** |
GB201516801D0 (en) | 2015-09-22 | 2015-11-04 | Immunovia Ab | Method, array and use thereof |
GB201608192D0 (en) * | 2016-05-10 | 2016-06-22 | Immunovia Ab | Method, array and use thereof |
GB201701572D0 (en) | 2017-01-31 | 2017-03-15 | Immunovia Ab | Methods, arrays and uses thereof |
WO2019232361A1 (fr) | 2018-05-31 | 2019-12-05 | University Of Florida Research Foundation | Traitement personnalisé du cancer du pancréas |
CN111171053B (zh) | 2020-01-06 | 2021-03-05 | 丽水市中心医院 | 一种化合物在制备治疗胰腺癌药物中的应用 |
GB202010970D0 (en) * | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
-
2008
- 2008-03-25 CN CN201710115906.1A patent/CN107102142A/zh active Pending
- 2008-03-25 EP EP12163644A patent/EP2490025A3/fr not_active Withdrawn
- 2008-03-25 WO PCT/GB2008/001090 patent/WO2008117067A2/fr active Application Filing
- 2008-03-25 EP EP08718919.7A patent/EP2140269B1/fr active Active
- 2008-03-25 JP JP2010500358A patent/JP6115801B2/ja active Active
- 2008-03-25 US US12/593,448 patent/US20100105571A1/en not_active Abandoned
- 2008-03-25 EP EP20214718.7A patent/EP3851856A3/fr active Pending
- 2008-03-25 DK DK08718919.7T patent/DK2140269T3/da active
- 2008-03-25 AU AU2008231575A patent/AU2008231575A1/en not_active Abandoned
- 2008-03-25 PL PL08718919T patent/PL2140269T3/pl unknown
- 2008-03-25 CN CN200880013776A patent/CN101680896A/zh active Pending
- 2008-03-25 ES ES08718919.7T patent/ES2442919T3/es active Active
- 2008-03-25 CA CA2681899A patent/CA2681899C/fr active Active
-
2014
- 2014-07-18 AU AU2014204510A patent/AU2014204510C1/en active Active
-
2015
- 2015-05-28 JP JP2015108468A patent/JP2015187611A/ja active Pending
-
2016
- 2016-10-07 AU AU2016238939A patent/AU2016238939B2/en active Active
-
2017
- 2017-01-06 JP JP2017000956A patent/JP6465902B2/ja active Active
- 2017-05-08 US US15/589,084 patent/US20170307620A1/en not_active Abandoned
-
2019
- 2019-09-23 US US16/578,768 patent/US11525832B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004055519A2 (fr) * | 2002-12-17 | 2004-07-01 | Sinogenomax Co. Ltd. | Marqueurs specifiques pour le cancer du pancreas |
Non-Patent Citations (5)
Title |
---|
BLOOMSTON MARK ET AL: "Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 66, no. 5, 1 March 2006 (2006-03-01), pages 2592 - 2599, XP002484528, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-05-3659 * |
ELLMARK PETER ET AL: "Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays", MOLECULAR & CELLULAR PROTEOMICS, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 5, no. 9, 1 January 2006 (2006-01-01), pages 1638 - 1646, XP002528853, ISSN: 1535-9476, DOI: 10.1074/MCP.M600170-MCP200 * |
GARCEA ET AL: "Molecular prognostic markers in pancreatic cancer: A systematic review", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 41, no. 15, 1 October 2005 (2005-10-01), pages 2213 - 2236, XP005104215, ISSN: 0959-8049 * |
MIN JUNG LEE ET AL: "Identification of Human Complement Factor B as a Novel Biomarker Candidate for Pancreatic Ductal Adenocarcinoma", JOURNAL OF PROTEOME RESEARCH, vol. 13, no. 11, 7 November 2014 (2014-11-07), pages 4878 - 4888, XP055236746, ISSN: 1535-3893, DOI: 10.1021/pr5002719 * |
SUMIYOSHI KEN-ICHI ET AL: "Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas", JOURNAL OF GASTROENTERLOGY, vol. 32, no. 3, 1 May 1997 (1997-05-01), JP, pages 367 - 373, XP055802628, ISSN: 0944-1174, Retrieved from the Internet <URL:https://link.springer.com/content/pdf/10.1007/BF02934495.pdf> DOI: 10.1007/BF02934495 * |
Also Published As
Publication number | Publication date |
---|---|
AU2014204510C1 (en) | 2017-01-19 |
ES2442919T3 (es) | 2014-02-14 |
EP2490025A2 (fr) | 2012-08-22 |
PL2140269T3 (pl) | 2014-07-31 |
AU2016238939A1 (en) | 2016-11-03 |
WO2008117067A3 (fr) | 2008-11-20 |
WO2008117067A2 (fr) | 2008-10-02 |
CN101680896A (zh) | 2010-03-24 |
JP2010522875A (ja) | 2010-07-08 |
EP2490025A3 (fr) | 2012-11-28 |
WO2008117067A8 (fr) | 2009-04-16 |
AU2014204510B2 (en) | 2016-10-27 |
CN107102142A (zh) | 2017-08-29 |
US20100105571A1 (en) | 2010-04-29 |
DK2140269T3 (da) | 2013-12-16 |
AU2008231575A1 (en) | 2008-10-02 |
US20170307620A1 (en) | 2017-10-26 |
US20200018760A1 (en) | 2020-01-16 |
CA2681899A1 (fr) | 2008-10-02 |
US11525832B2 (en) | 2022-12-13 |
AU2014204510A1 (en) | 2014-08-07 |
AU2016238939B2 (en) | 2018-08-02 |
EP2140269B1 (fr) | 2013-11-20 |
JP6115801B2 (ja) | 2017-04-19 |
EP3851856A2 (fr) | 2021-07-21 |
JP6465902B2 (ja) | 2019-02-06 |
WO2008117067A9 (fr) | 2008-12-31 |
JP2017067792A (ja) | 2017-04-06 |
CA2681899C (fr) | 2018-06-19 |
EP2140269A2 (fr) | 2010-01-06 |
JP2015187611A (ja) | 2015-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3851856A3 (fr) | Procédé, réseau et son utilisation | |
WO2012120288A3 (fr) | Procédé, réseau et utilisation associée | |
DK1766400T3 (da) | Fremgangsmåde til at udföre fuldblodsanalyser | |
DE602007011937D1 (de) | Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie | |
GB2474146A (en) | Methods of determining the health status of an individual | |
GB201014837D0 (en) | Biomarker signatures and uses thereof | |
WO2007140291A3 (fr) | Quantification d'expression par spectrométrie de masse | |
WO2009007846A3 (fr) | Procédé pour modifier, isoler, détecter, visualiser et quantifier des peptides, polypeptides et protéines contenant de la citrulline et/ou de l'homocitrulline | |
WO2017050939A3 (fr) | Méthode, ensemble et leur utilisation | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
CA2815892C (fr) | Procedes d'analyse et puces utilisables a cet effet | |
ATE443775T1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
WO2017194613A3 (fr) | Méthode, réseau et leur utilisation | |
EP1718768A4 (fr) | Procedes et compositions pour la determination de phenotype a tolerance vis-a-vis du greffon chez un sujet | |
NZ609824A (en) | Immunochromatography devices, methods and kits | |
WO2009073505A3 (fr) | Procédés de traitement de données de spectres de masse en tandem pour une analyse de séquence d'une protéine | |
MX2009013009A (es) | Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico. | |
WO2008151207A3 (fr) | Quantification d'expression utilisant une spectrométrie de masse | |
ATE514081T1 (de) | T-zellen-testverfahren | |
WO2009023331A3 (fr) | Anticorps et procédés améliorés de manipulation d'un échantillon test destinés à être utilisés dans des dosages pour myélopéroxidase | |
MX2009001070A (es) | Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma. | |
ATE354635T1 (de) | Substrat und verfahren zum messen elektrophysiologischer eigenschaften von zellmembranen | |
EP3557259A3 (fr) | Procédés et réseaux destinés à être utilisés avec ceux-ci | |
EP1408120A3 (fr) | Détection des sous-espèces d'Enterococcus vancomycin-résistantes | |
WO2007149486A3 (fr) | Méthodes et matériels pour observer une apoptose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201216 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2490025 Country of ref document: EP Kind code of ref document: P Ref document number: 2140269 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/574 20060101AFI20210929BHEP |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230524 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240104 |